Please login to the form below

ESMO congress

This page shows the latest ESMO congress news and features for those working in and with pharma, biotech and healthcare.

BMS’ Opdivo wins EU approval for second-line oesophageal cancer

In September, Merck presented results from the KEYNOTE-590 trial at the 2020 European Society for Medical Oncology (ESMO) virtual congress, which evaluated Keytruda in combination with chemotherapy in first-line ... Opdivo is also chasing approval in the

Latest news

Merck, Eisai’s Keytruda plus Lenvima combo hits the mark in renal cancer

Data presented at the 2020 European Society for Medical Oncology (ESMO) virtual congress detailed a 40% reduction in the risk of death among previously untreated RCC patients receiving Opdivo plus Cabometyx
Lilly’s Verzenio scores a win in early-stage breast cancer

Positive data was presented at 2020 ESMO virtual congress. Eli Lilly’s Verzenio has scored positive results in early breast cancer, cutting the risk of disease recurrence by 25% when given
Janssen’s EGFR-targeting treatment regimen shows early benefit in lung cancer

Positive interim results presented at 2020 ESMO virtual congress. Janssen, the pharmaceutical division of Johnson &Johnson, has revealed positive interim results from a phase 1 study of its investigational bispecific antibody ... The results, presented
AZ/Merck's Lynparza improves survival in certain prostate cancers

New data released at ESMO 2020 virtual congress shows drug cuts the risk of death. ... AstraZeneca/Merck &Co’s PARP inhibitor Lynparza cut the risk of death in new data released at the 2020 European Society for Medical Oncology (ESMO) virtual congress.
Keytruda plus chemotherapy cuts risk of death by 27% in advanced oesophageal cancer

New data from KEYNOTE-590 trial was presented at ESMO 2020 virtual congress. ... The results from the KEYNOTE-590 trial, presented at the 2020 European Society for Medical Oncology (ESMO) virtual congress, showed that Keytruda in combination with

More from news
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest from PMHub

Creative review: ESMO 2018

BLH reviews the creative concepts exhibited at the European Society for Medical Oncology (ESMO) 2018 Congress, crowning our best booth winners and giving key insights on how to develop an inspiring ... On October 19th the team from Blue Latitude Health
ESMO 2012 Video and Social Media Highlights

Brandcast Health's take on the highlights from the ESMO 2012 congress in Vienna, Austria, including social media insights.
Blue Latitude Health

As hard as congress organisers try, replicating the congress experience on a virtual platform is difficult. ... BLH reviews the creative concepts exhibited at the European Society for Medical Oncology (ESMO) 2018 Congress, crowning our best booth winners

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

Healthcare Lead Copywriter: Competitive

Account Director – Creative Healthcare Communications: Competative

Medical Editor: Competitive

Account Manager Healthcare / Pharmaceutical Sector: Negotiable Salary

Healthcare Senior Account Manager: Competitive

Sales Director, Healthcare communications agency, London/ SE UK: Six figure salary

Healthcare Account Director: Competitive

PMHub

Add my company

Langland

We love what we do and we think it shows.It shows in the work we do, the space we work...

Latest intelligence

AstraZeneca’s focus on diagnosing and managing chronic kidney disease: People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story: How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
Three ways AI will change healthcare in the next decade: Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...